Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-04

Clinical Trial Update: Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cisplatin and ifosfamide with either paclitaxel or vinblastine for progressive or recurrent metastatic germ cell tumors has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • IFOSFAMIDE (IFOSFAMIDE)
  • PACLITAXEL (PACLITAXEL)
  • Vinblastine (vinblastine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor | Phase 3 | Status: TERMINATED